The role of genetic diversity in cancer

od Merlo, Lauren M.F., Maley, Carlo C.
Izdano 2010

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity

od Merlo, Lauren M.F., Mandik-Nayak, Laura
izdano v Clin Med Insights Pathol (2016)

An empirical test of the concomitantly variable codon hypothesis

od Merlo, Lauren M. F., Lunzer, Mark, Dean, Antony M.
Izdano 2007

Cancer in Light of Experimental Evolution

od Sprouffske, Kathleen, Merlo, Lauren M.F., Gerrish, Philip J., Maley, Carlo C., Sniegowski, Paul D.
Izdano 2012

IDO2 in Immunomodulation and Autoimmune Disease

od Prendergast, George C., Metz, Richard, Muller, Alexander J., Merlo, Lauren M. F., Mandik-Nayak, Laura
izdano v Front Immunol (2014)

Development and Characterization of an Organotypic Model of Barrett’s Esophagus

od Kosoff, Rachelle E., Gardiner, Kristin L., Merlo, Lauren M.F., Pavlov, Kirill, Rustgi, Anil K., Maley, Carlo C.
Izdano 2012

IDO2 modulates T cell-dependent autoimmune responses through a B cell-intrinsic mechanism

od Merlo, Lauren M.F., DuHadaway, James B., Grabler, Samantha, Prendergast, George C., Muller, Alexander J., Mandik-Nayak, Laura
izdano v J Immunol (2016)

IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis()

od Merlo, Lauren M.F., Pigott, Elizabeth, DuHadaway, James B., Grabler, Samantha, Metz, Richard, Prendergast, George C., Mandik-Nayak, Laura
Izdano 2014

A comprehensive survey of clonal diversity measures in Barrett’s esophagus as biomarkers of progression to esophageal adenocarcinoma

od Merlo, Lauren M.F., Shah, Najaf A., Li, Xiaohong, Blount, Patricia L., Vaughan, Thomas L., Reid, Brian J., Maley, Carlo C.
Izdano 2010

Therapeutic Antibody Targeting of Indoleamine-2,3-Dioxygenase (IDO2) Inhibits Autoimmune Arthritis

od Merlo, Lauren M.F., Grabler, Samantha, DuHadaway, James B., Pigott, Elizabeth, Manley, Kaylend, Prendergast, George C., Laury-Kleintop, Lisa D., Mandik-Nayak, Laura
izdano v Clin Immunol (2017)

Application of simultaneous selective pressures slows adaptation

od Merlo, Lauren M. F., Sprouffske, Kathleen, Howard, Taylor C., Gardiner, Kristin L., Caulin, Aleah F., Blum, Steven M., Evans, Perry, Bedalov, Antonio, Sniegowski, Paul D., Maley, Carlo C.
izdano v Evol Appl (2020)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses

od Merlo, Lauren M. F., DuHadaway, James B., Montgomery, James D., Peng, Wei-Dan, Murray, Peter J., Prendergast, George C., Caton, Andrew J., Muller, Alexander J., Mandik-Nayak, Laura
izdano v Front Immunol (2020)

IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation

od Metz, Richard, Smith, Courtney, DuHadaway, James B., Chandler, Phillip, Baban, Babak, Merlo, Lauren M. F., Pigott, Elizabeth, Keough, Martin P., Rust, Sonja, Mellor, Andrew L., Mandik-Nayak, Laura, Muller, Alexander J., Prendergast, George C.
izdano v Int Immunol (2014)

Corrigendum: IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation

od Metz, Richard, Smith, Courtney, DuHadaway, James B, Chandler, Phillip, Baban, Babak, Merlo, Lauren M F, Pigott, Elizabeth, Keough, Martin P, Rust, Sonja, Mellor, Andrew L, Mandik-Nayak, Laura, Muller, Alexander J, Prendergast, George C
izdano v Int Immunol (2019)

Peptide vaccination directed against IDO1-expressing immune cells elicits CD8(+) and CD4(+) T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

od Dey, Souvik, Sutanto-Ward, Erika, Kopp, Katharina L, DuHadaway, James, Mondal, Arpita, Ghaban, Dema, Lecoq, Inés, Zocca, Mai-Britt, Merlo, Lauren M F, Mandik-Nayak, Laura, Andersen, Mads Hald, Pedersen, Ayako Wakatsuki, Muller, Alexander J
izdano v J Immunother Cancer (2020)